Cochlear implantation in a patient with a POU4F3 mutation

Keitaro Miyake; Kyoko Shirai; Nobuhiro Nishiyama; Sachie Kawaguchi; Yoko Ohta; Atsushi Kawano; Shin-Ichi Usami; Tomohiro Kitano; Kiyoaki Tsukahara

doi:10.1002/ccr3.3520

Cochlear implantation in a patient with a POU4F3 mutation

Clin Case Rep. 2020 Nov 11;9(1):298-303. doi: 10.1002/ccr3.3520. eCollection 2021 Jan.

Authors

Keitaro Miyake¹, Kyoko Shirai¹, Nobuhiro Nishiyama², Sachie Kawaguchi³, Yoko Ohta¹, Atsushi Kawano¹, Shin-Ichi Usami⁴, Tomohiro Kitano⁵, Kiyoaki Tsukahara¹

Affiliations

¹ Department of Otolaryngology, Head and Neck Surgery Tokyo Medical University Shinjuku-ku Japan.
² Department of Clinical Oncology Tokyo Medical University Ibaraki Medical Center Inashiki-gun Japan.
³ Department of Otorhinolaryngology Yokohama Asahi Chuo General Hospital Yokohama-shi Japan.
⁴ Department of Hearing Implant Sciences Shinshu University School of Medicine Matsumoto-shi Japan.
⁵ Department of Otorhinolaryngology Shinshu University School of Medicine Matsumoto-shi Japan.

Abstract

Cochlear implants (CIs) are generally considered useful in the treatment of hereditary hearing loss with progressive deafness. Early CI can be beneficial for maintaining social activities in POU4F3 mutation patients.

Keywords: POU4F3; cochlear implant surgery; progressive hearing loss; residual hearing; surgery timing.

Publication types

Case Reports